ArticleIrish journal of medical science2026
A multi-faceted, human-centred approach to enhance the assessment and management of children with allergic rhinitis.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAllergic rhinitis is an IgE-mediated disease with a prevalence of 10.48%. Licari et al., (2023) J Allergy Clin Immunol Pract 11(8) 2547-2556, It affects children's quality of life, from poor academic performance to poor smell and voice. Our aims were to assess and enhance the management of children with allergic rhinitis from primary care to secondary care.
methodsThis is a two-stage, prospective cross-sectional study utilizing a multidisciplinary team approach. Stage one assessed the management of allergic rhinitis amongst primary and secondary care. The second stage took a human centred approach to review the patient's pathway within secondary care. These insights were used to develop assessment and educational tools. Questionnaires were distributed to general practitioners (GPs), pharmacists and patients.
resultsOne hundred completed questionnaires were returned (39 GPs, 61 pharmacists). Twenty-six per cent of respondents reported giving the correct advice regarding intranasal corticosteroid sprays (INCS). In secondary care, 106 children were reviewed. Twenty-four parents completed feedback forms, all felt the parent proforma was easy to complete and helpful to their appointment. Clinician feedback was overall positive and found, "The proforma and preformatted prescription improved efficiency and allowed more consultation time to explain the technique and importance of daily use of the steroid nasal spray". In the later stages of this study, discharge rates for new patients were 78.4%.
conclusionThis study highlights a team-based, patient centred approach to enhance the assessment and management of children with allergic rhinitis. The team created a standardized means of assessment and developed management algorithms to assist community and hospital care providers.
Indexed as
Identifiers
41283943What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.